BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Prognosis
13 results:

  • 1. [Interim results of a multicenter cohort study for Chinese Children Leukemia Group-acute lymphoblastic leukemia 2018 regimen].
    Chinese Children Leukemia Group
    Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):874-880. PubMed ID: 37803853
    [No Abstract]    [Full Text] [Related]  

  • 2. Predictive Modelling of Overall Survival in Adult Patients with Primary Diffuse Large B-cell lymphoma of the Breast Using the Surveillance, Epidemiology, and End Results (SEER) Database.
    Liu Y; Han H; Wei H; Wang X; Luan Z; Jiang K
    Recent Pat Anticancer Drug Discov; 2024; 19(3):373-382. PubMed ID: 37464821
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The characteristics and survival of second primary lung cancer after Hodgkin's lymphoma: A comparison with first primary lung cancer using the SEER database.
    Lin L; Wang D; Chen H
    PLoS One; 2023; 18(5):e0285766. PubMed ID: 37195975
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL.
    Staiger AM; Altenbuchinger M; Ziepert M; Kohler C; Horn H; Huttner M; Hüttl KS; Glehr G; Klapper W; Szczepanowski M; Richter J; Stein H; Feller AC; Möller P; Hansmann ML; Poeschel V; Held G; Loeffler M; Schmitz N; Trümper L; Pukrop T; Rosenwald A; Ott G; Spang R; ;
    Leukemia; 2020 Feb; 34(2):543-552. PubMed ID: 31530861
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Efficacy of RCDOP regimen in the treatment of patients with diffuse large B-cell lymphoma].
    Cao YW; Shi Q; Zhang MC; Xu PP; Chen S; Zhao WL; Wang L
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):485-490. PubMed ID: 30032566
    [No Abstract]    [Full Text] [Related]  

  • 6. Analysis of relapse after transplantation in acute leukemia: A comparative on second allogeneic hematopoietic cell transplantation and donor lymphocyte infusions.
    Ortí G; Sanz J; García-Cadenas I; Sánchez-Ortega I; Alonso L; Jiménez MJ; Sisinni L; Azqueta C; Salamero O; Badell I; Ferra C; de Heredia CD; Parody R; Sanz MA; Sierra J; Piñana JL; Querol S; Valcárcel D
    Exp Hematol; 2018 Jun; 62():24-32. PubMed ID: 29526774
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Clinicopathologic and molecular characteristics of malignant gastrointestinal neuroectodermal tumors].
    Zhao M; Zhao TW; Ma J; Wu CY; Chen L; Ru GQ; He XL
    Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):750-755. PubMed ID: 29136686
    [No Abstract]    [Full Text] [Related]  

  • 8. Late Relapse of Classical Hodgkin lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials.
    Bröckelmann PJ; Goergen H; Kohnhorst C; von Tresckow B; Moccia A; Markova J; Meissner J; Kerkhoff A; Ludwig WD; Fuchs M; Borchmann P; Engert A
    J Clin Oncol; 2017 May; 35(13):1444-1450. PubMed ID: 28240973
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion.
    Subbiah V; Holmes O; Gowen K; Spritz D; Amini B; Wang WL; Schrock AB; Meric-Bernstam F; Zinner R; Piha-Paul S; Zarzour M; Elvin JA; Erlich RL; Stockman DL; Vergilio JA; Suh JH; Stephens PJ; Miller V; Ross JS; Ali SM
    Oncology; 2016; 91(6):348-353. PubMed ID: 27764830
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004.
    Shibamoto Y; Ogino H; Suzuki G; Takemoto M; Araki N; Isobe K; Tsuchida E; Nakamura K; Kenjo M; Suzuki K; Hosono M; Tokumaru S; Ishihara S; Kato E; Ii N; Hayabuchi N
    Neuro Oncol; 2008 Aug; 10(4):560-8. PubMed ID: 18559969
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Primary anaplastic large cell lymphoma of the central nervous system: prognostic effect of ALK-1 expression.
    George DH; Scheithauer BW; Aker FV; Kurtin PJ; Burger PC; Cameselle-Teijeiro J; McLendon RE; Parisi JE; Paulus W; Roggendorf W; Sotelo C
    Am J Surg Pathol; 2003 Apr; 27(4):487-93. PubMed ID: 12657933
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The prognostic significance of serum levels of soluble intercellular adhesion molecules-1 in patients with primary extranodal non-Hodgkin lymphomas.
    Lei KI; Johnson PJ
    Cancer; 2000 Sep; 89(6):1387-95. PubMed ID: 11002235
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Primary central nervous system lymphoma in Japan: a nationwide survey.
    Hayabuchi N; Shibamoto Y; Onizuka Y
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):265-72. PubMed ID: 10760418
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.